Purchase Order 36C24225P0975

Award Date 5/9/25
Potential Completion Date 9/30/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's Optune Plus system, which delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. This is a firm-fixed-price purchase order with a period of performance running through...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 (VISN 8) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the procurement of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers in a non-invasive manner. The...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order is for the provision of Novocure's Optune Plus transducer devices, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma in veteran patients. The award is part of a larger $28.85 million Federal...
This federal contract award, with an ID of 36F79723D0016|36C26023F0188, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducer, a device that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The award is issued under...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA...
This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $33,165.82 firm fixed-price delivery order contract is for the provision of Novocure's Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma. The contract is part of a larger $28.85 million Federal...
This federal contract award, with ID 36C24622P0951, was issued by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $84,000.00 firm fixed-price purchase order is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This delivery order is issued under...

This federal contract award, with an ID of 36C24225P0975, was made by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $49,748.73 firm fixed-price purchase order is for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers. This contract does not have a set-aside designation.

Novocure holds a significant $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with the VA VHA, which serves as the primary procurement vehicle for the VA to obtain Novocure's medical technologies. Under this FSS contract, various VA regional networks have issued numerous delivery orders to Novocure, enabling the VA to expand veterans' access to this innovative, non-invasive cancer treatment technology across multiple medical facilities nationwide.

Generated 5/14/25, 10:31 AM